NT‐proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure

N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a well‐established biomarker in heart failure (HF) but controversially discussed as a potential surrogate marker in HF trials. We analyzed the NT‐proBNP/mortality relationship in real‐world data (RWD) of 108,330 HF patients from the IBM Watson...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Walter, Rühs, Hauke, Burghaus, Rolf, Diedrich, Christian, Duwal, Sulav, Eissing, Thomas, Garmann, Dirk, Meyer, Michaela, Ploeger, Bart, Lippert, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360001/
https://www.ncbi.nlm.nih.gov/pubmed/33630302
http://dx.doi.org/10.1002/cpt.2222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360001/
https://www.ncbi.nlm.nih.gov/pubmed/33630302
http://dx.doi.org/10.1002/cpt.2222

Ejemplares similares